Panelists discuss how the heterogeneity of bronchiectasis requires precise phenotyping and a treatable traits approach to address varying symptom profiles, from cough-predominant to shortness of breath–predominant presentations.
Clinical Brief: Challenges in Managing Heterogeneous Bronchiectasis Presentations
Main Discussion Topics
Key Points for Physicians
Notable Insights
The heterogeneity of bronchiectasis necessitates precision medicine approaches tailored to individual patient presentations rather than standardized treatment algorithms.
Clinical Significance
Recognizing and addressing the varied presentations of bronchiectasis through phenotype-specific approaches improves management outcomes and patient quality of life.
Lack of CD20 Expression Worsens Outcomes for Bispecifics in R/R DLBCL
July 16th 2025Real-world analysis reveals that undetectable CD20 expression worsens outcomes for patients treated with epcoritamab and glofitamab bispecific antibodies for their diffuse large B-cell lymphoma (DLBCL).
Read More